Literature DB >> 14522147

Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage.

Harald Sontheimer1.   

Abstract

The malignant transformation of astrocytes, oligodendrocytes or their progenitor cells gives rise to tumors that are collectively called gliomas. Although the vast majority of these tumors are believed to be of astrocytic origin, the actual cell of origin remains unknown. And whereas gliomas present with some genetic alterations in tumor-suppressor genes or oncogenes that are common among cancers, their biology differs significantly from other neoplasms. Most notably, they grow in a confined space defined by the bones of the skull and spinal column, and they spread by active cell migration rather than by passive, humorous spread. Recent research suggests that astrocyte-derived tumors co-opt neurotransmitters, their transporters and ion channels to support their unusual growth and invasive migration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522147     DOI: 10.1016/j.tins.2003.08.007

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  45 in total

Review 1.  Glutamate and the biology of gliomas.

Authors:  John de Groot; Harald Sontheimer
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

Review 2.  The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas.

Authors:  Florence Lefranc; Robert Kiss
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

3.  Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression.

Authors:  Jan Lewerenz; Pamela Maher
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

4.  Targeting putative mu opioid/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer model.

Authors:  Branden A Smeester; Mary M Lunzer; Eyup Akgün; Alvin J Beitz; Philip S Portoghese
Journal:  Eur J Pharmacol       Date:  2014-09-17       Impact factor: 4.432

5.  Inhibition of cystine uptake disrupts the growth of primary brain tumors.

Authors:  Wook Joon Chung; Susan A Lyons; Gina M Nelson; Hashir Hamza; Candece L Gladson; G Yancey Gillespie; Harald Sontheimer
Journal:  J Neurosci       Date:  2005-08-03       Impact factor: 6.167

6.  Glioma big potassium channel expression in human cancers and possible T cell epitopes for their immunotherapy.

Authors:  Lisheng Ge; Neil T Hoa; Andrew N Cornforth; Daniela A Bota; Anthony Mai; Dong In Kim; Shiun-Kwei Chiou; Michelle J Hickey; Carol A Kruse; Martin R Jadus
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

7.  Water permeability through aquaporin-4 is regulated by protein kinase C and becomes rate-limiting for glioma invasion.

Authors:  E S McCoy; B R Haas; H Sontheimer
Journal:  Neuroscience       Date:  2009-09-15       Impact factor: 3.590

8.  Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB.

Authors:  W Joon Chung; Harald Sontheimer
Journal:  J Neurochem       Date:  2009-04-29       Impact factor: 5.372

9.  Combined treatment of fasudil and glutamate decreased the viability of human glioblastoma cells by excitotoxicity through NMDAR in vitro.

Authors:  Mingliang He; Ming Luo; Shu Chen; Kaishu Li; Meiguang Zheng; Yinlun Weng; Rongbiao Pi; Anmin Liu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Glioblastoma cells express functional cell membrane receptors activated by daily used medical drugs.

Authors:  Susanne A Kuhn; Ulrike Mueller; Uwe-K Hanisch; Christian R A Regenbrecht; Ilona Schoenwald; Michael Brodhun; Hartwig Kosmehl; Christian Ewald; Rolf Kalff; Rupert Reichart
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-19       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.